New on BloFin: $ABBV.USDT stock perp, AbbVie, a US pharma giant, up to 20x

BloFin ABBV stock perp notes, official BloFin contract data around 11:54 AM ET Oct 27:

What it is: a USDT-margined linear perp (ABBV-USDT) tracking AbbVie (NYSE: ABBV), the US pharmaceutical company behind Humira, Skyrizi and Rinvoq. Listed in BloFin's stock perps at 3:30 AM ET today. Max 20x, contract value 0.01 ABBV, minimum order 1 contract, funding every 8 hours.

Live stats: 24h range 283.30 to 287.50, last ~286.59, essentially flat against the 24h open of 286.56. Funding is about flat at +0.0027% per 8h. 24h volume about 24.9 ABBV (roughly 7.1K USDT), so books are thin.

Market structure (15m): the 283.30 low was a single wick in the 9:30 candle. Since then lows climbed, then flattened (285.30, 285.79, 286.31, 286.43, 286.30, 286.45, 286.25) while highs keep stalling at 287.01 to 287.13, so price is coiling just under that ceiling inside a 286.25 to 287.13 band. Early read on very thin volume.

Bias: LONG. Setup: dips that hold 286.25 (the lower edge of the band), aiming for a 15m close above 287.13. Invalidation: 15m close below 285.79, which breaks the higher-low sequence. Key levels: 283.30 wick low, 285.79 / 286.25 support, 287.03 / 287.13 ceiling, 287.50 24h high.

Risk: brand new contract, very thin books, so one order can move it, and it follows US market hours. Size small. Not financial advice.

Bias: LONG dips that hold 286.25.